Live TVLive TV
News18 » India
1-min read

Compulsory licencing of Bayer's cancer drug is a triumph

Dinesh Narayanan

First published: May 12, 2012, 2:17 PM IST | Updated: May 12, 2012
facebook Twitter google skype whatsapp
Compulsory licencing of Bayer's cancer drug is a triumph
WHO's country head Nata Menabde tells Forbes India that governments should take measures to improve access to life-saving drugs, but be sensitive to pharmaceutical industry's concerns.
facebook Twitter google skype whatsapp